Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 262

Results For "Clinic"

3637 News Found

Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications
News | June 21, 2022

Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications

It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.


Indira IVF inaugurates new centre in Delhi Patel Nagar
Healthcare | June 21, 2022

Indira IVF inaugurates new centre in Delhi Patel Nagar

Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate


Cipla signs agreement for acquisition of 21.05% stake in Achira Labs
News | June 20, 2022

Cipla signs agreement for acquisition of 21.05% stake in Achira Labs

This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies


Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation
News | June 18, 2022

Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation

Both manufacturing facilities are based out of Benguluru, India


GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
People | June 17, 2022

GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer

Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics


Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
Drug Approval | June 16, 2022

Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation

Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation


LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
News | June 16, 2022

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA

With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development


COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
Healthcare | June 16, 2022

COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute

Many kids who have heart transplants live a normal, healthy life once they recover from surgery.


EPR-Technologies announces new approach to emergency care when CPR fails
Healthcare | June 16, 2022

EPR-Technologies announces new approach to emergency care when CPR fails

EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails


ProBioGen  and ValenzaBio enter second service agreement
Biotech | June 15, 2022

ProBioGen and ValenzaBio enter second service agreement

The new program includes upstream and downstream process development and large-scale GMP production.